| 1 |
32306906 | Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells. | 2020 Apr 19 |
1 |
| 2 |
30962952 | The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma. | 2019 |
1 |
| 3 |
30292139 | A Novel Aurora-A Inhibitor (MLN8237) Synergistically Enhances the Antitumor Activity of Sorafenib in Hepatocellular Carcinoma. | 2018 Dec 7 |
1 |
| 4 |
28855436 | Effects of sorafenib and an adenylyl cyclase activator on in vitro growth of well-differentiated thyroid cancer cells. | 2017 Nov 29 |
2 |
| 5 |
20950443 | The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells. | 2010 Oct 15 |
1 |
| 6 |
16959960 | Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells. | 2006 Dec |
1 |